Dr. Michael Hamblin stands as one of the world’s foremost researchers in Photobiomodulation. His decades of rigorous scientific inquiry have been instrumental in establishing PBM as a legitimate and powerful therapeutic modality. With a PhD and deep expertise in laser medicine and specialization in biophotonics, his contributions are foundational to the entire field.

As a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital and former Associate Professor of Dermatology at Harvard Medical School, Dr. Hamblin has consistently been at the forefront of PBM research, driving the field forward and establishing its scientific credibility. His work, supported by leading institutions like the NIH and USAFOSR, has translated complex scientific principles into a deep understanding of PBM’s diverse applications and therapeutic potential, providing the evidence base for technologies aimed at harnessing light for healing, such as those offered by PBM Healing.

His prolific output, evidenced by over 620 peer-reviewed articles and numerous textbooks, has not only shaped the scientific discourse around Photobiomodulation but has also provided invaluable insights directly relevant to the engineering and application of PBM technologies seeking to deliver real-world benefits.